RxDoctor Payments Data

Carrie English

Family · Spartansburg, PANPI 1023745940

Payments from drug & device makers

$2,620in general payments, 2019–2025

Across 167 payments — averaging $15.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$899
  • AbbVie$418
  • Lilly USA, LLC$280
  • AstraZeneca$190
  • Otsuka America Pharmaceutical, Inc.$176
  • GSK$144
  • plus $513 from 14 others

What the payments were for

  • Food & beverage$2,620100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,620 in reported general payments places this provider in the 85th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide70$88,318
EliquisApixaban73$48,053
RybelsusSemaglutide20$31,212
JardianceEmpagliflozin29$23,124
MounjaroTirzepatide17$18,398
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$18,359
FarxigaDapagliflozin Propanediol17$15,439
TradjentaLinagliptin14$10,677
Breo ElliptaFluticasone/Vilanterol19$9,923
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog15$4,922
Levothyroxine Sodium161$2,606
Albuterol Sulfate HfaAlbuterol Sulfate103$2,348
Fenofibrate21$2,100
Pantoprazole Sodium131$1,341
Armour ThyroidThyroid,pork18$1,246

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$899$119,52990 claims
PfizerEliquis$46$48,05373 claims
Boehringer IngelheimJardiance, Tradjenta$18$33,80243 claims
GSKTrelegy Ellipta, Breo Ellipta$144$28,28343 claims
Lilly USA, LLCMounjaro$280$18,39817 claims
AstraZenecaFarxiga$190$15,43917 claims
AbbVieArmour Thyroid, Synthroid$418$2,30644 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,717 family providers in Pennsylvania.

Other family in Spartansburg

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →